Skip to main
BCAX
BCAX logo

BCAX P/E Ratio

P/E Ratio as of Jun 13, 2025: -6.39

Average-6.66
Median-6.67
Minimum-7.42
Maximum-5.84
-6.39
The P/E ratio for BCAX is -6.39 as of Jun 13, 2025. This represents a increase of 1,204.08% compared to its 12-month average P/E ratio of -0.49. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Bicara Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Bicara Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Bicara Therapeutics Inc to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BCAX P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$9.90-5.84

BCAX End of Year P/E Ratio

DateP/E ratioChange
2025-6.39

FAQs About Bicara Therapeutics Inc (BCAX) P/E ratio

The latest P/E ratio of BCAX is -6.39, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Bicara Therapeutics Inc’s last 12-month average P/E ratio is -0.49, compared to its current P/E ratio of -6.39. This reflects a increase of 1,204.08%.

Bicara Therapeutics Inc’s current P/E ratio of -6.39 is higher than its last 12-month average P/E of -0.49. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Bicara Therapeutics Inc’s average P/E ratio over the last 3 years is -0.16. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Bicara Therapeutics Inc’s average P/E ratio over the last 5 years is -0.1. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Bicara Therapeutics Inc (BCAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.